Assessment of drug-drug interactions in hypertensive patients at a superspeciality hospital

Objective: The objective of the study was to assess the incidence and pattern of drug-drug interactions (DDIs) in hypertensive patients by using Micromedex and Medscape databases. Materials and Methods: A prospective observational study was carried out in a superspeciality hospital setting...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Divya Sivva, Uday Venkat Mateti, Venu Madhav Neerati, Nimbagiri Swamy Thiruthopu, Srinivas Martha
Formato: article
Lenguaje:EN
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2015
Materias:
R
Acceso en línea:https://doaj.org/article/360f68c8f3a549afaf3c0e5714c7c2be
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:360f68c8f3a549afaf3c0e5714c7c2be
record_format dspace
spelling oai:doaj.org-article:360f68c8f3a549afaf3c0e5714c7c2be2021-12-02T17:59:03ZAssessment of drug-drug interactions in hypertensive patients at a superspeciality hospital2231-07702249-446410.4103/2231-0770.154194https://doaj.org/article/360f68c8f3a549afaf3c0e5714c7c2be2015-04-01T00:00:00Zhttp://www.thieme-connect.de/DOI/DOI?10.4103/2231-0770.154194https://doaj.org/toc/2231-0770https://doaj.org/toc/2249-4464Objective: The objective of the study was to assess the incidence and pattern of drug-drug interactions (DDIs) in hypertensive patients by using Micromedex and Medscape databases. Materials and Methods: A prospective observational study was carried out in a superspeciality hospital setting in South India for period of 9 months. Hypertensive patients who admitted into the hospital with the age more than 18 years, received more than 3 drugs per prescription and length of hospital stay for more than 24 hours were included in the study. An appropriate data was collected and assessed for DDIs with the help of Micromedex and Medscape databases. Results: A total of 227 patients were enrolled during the study period. Among the 227 patients, 48 of them developed 53 clinically significant DDIs. Out of 48 patients, most of them were in the age-group of 50-60 years [18 (37.49%)]. The percentage of DDIs were higher in males [30 (62.5%)] compared to females [18 (37.5%)]. The most common drugs responsible for DDIs in the present study were Insulin [18 (33.96%)] followed by Metoprolol [10 (18.86%)], Torsemide [8 (15.09%)], and Hydrochlorothiazide [8 (15.09%)]. The most commonly interacting pairs were Ciprofloxacin-Insulin [6 (11.32%)], followed by Metoprolol-Insulin [4 (7.54%)] and Atenolol-Insulin [4 (7.54%)]. The most common consequences of interacting pairs were reduced serum potassium levels and hyperglycemia. Conclusion: The overall incidence rate of DDIs was found to be 21.14% and the increasing number of co-morbidities ( P ≤ 0.003) and polypharmacy ( P ≤ 0.002) were the risk factor for the development of significant number of DDIs.Divya SivvaUday Venkat MatetiVenu Madhav NeeratiNimbagiri Swamy ThiruthopuSrinivas MarthaThieme Medical and Scientific Publishers Pvt. Ltd.articledrug-drug interactionshypertensionincidencemicromedexmedscapeMedicineRENAvicenna Journal of Medicine, Vol 05, Iss 02, Pp 29-35 (2015)
institution DOAJ
collection DOAJ
language EN
topic drug-drug interactions
hypertension
incidence
micromedex
medscape
Medicine
R
spellingShingle drug-drug interactions
hypertension
incidence
micromedex
medscape
Medicine
R
Divya Sivva
Uday Venkat Mateti
Venu Madhav Neerati
Nimbagiri Swamy Thiruthopu
Srinivas Martha
Assessment of drug-drug interactions in hypertensive patients at a superspeciality hospital
description Objective: The objective of the study was to assess the incidence and pattern of drug-drug interactions (DDIs) in hypertensive patients by using Micromedex and Medscape databases. Materials and Methods: A prospective observational study was carried out in a superspeciality hospital setting in South India for period of 9 months. Hypertensive patients who admitted into the hospital with the age more than 18 years, received more than 3 drugs per prescription and length of hospital stay for more than 24 hours were included in the study. An appropriate data was collected and assessed for DDIs with the help of Micromedex and Medscape databases. Results: A total of 227 patients were enrolled during the study period. Among the 227 patients, 48 of them developed 53 clinically significant DDIs. Out of 48 patients, most of them were in the age-group of 50-60 years [18 (37.49%)]. The percentage of DDIs were higher in males [30 (62.5%)] compared to females [18 (37.5%)]. The most common drugs responsible for DDIs in the present study were Insulin [18 (33.96%)] followed by Metoprolol [10 (18.86%)], Torsemide [8 (15.09%)], and Hydrochlorothiazide [8 (15.09%)]. The most commonly interacting pairs were Ciprofloxacin-Insulin [6 (11.32%)], followed by Metoprolol-Insulin [4 (7.54%)] and Atenolol-Insulin [4 (7.54%)]. The most common consequences of interacting pairs were reduced serum potassium levels and hyperglycemia. Conclusion: The overall incidence rate of DDIs was found to be 21.14% and the increasing number of co-morbidities ( P ≤ 0.003) and polypharmacy ( P ≤ 0.002) were the risk factor for the development of significant number of DDIs.
format article
author Divya Sivva
Uday Venkat Mateti
Venu Madhav Neerati
Nimbagiri Swamy Thiruthopu
Srinivas Martha
author_facet Divya Sivva
Uday Venkat Mateti
Venu Madhav Neerati
Nimbagiri Swamy Thiruthopu
Srinivas Martha
author_sort Divya Sivva
title Assessment of drug-drug interactions in hypertensive patients at a superspeciality hospital
title_short Assessment of drug-drug interactions in hypertensive patients at a superspeciality hospital
title_full Assessment of drug-drug interactions in hypertensive patients at a superspeciality hospital
title_fullStr Assessment of drug-drug interactions in hypertensive patients at a superspeciality hospital
title_full_unstemmed Assessment of drug-drug interactions in hypertensive patients at a superspeciality hospital
title_sort assessment of drug-drug interactions in hypertensive patients at a superspeciality hospital
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
publishDate 2015
url https://doaj.org/article/360f68c8f3a549afaf3c0e5714c7c2be
work_keys_str_mv AT divyasivva assessmentofdrugdruginteractionsinhypertensivepatientsatasuperspecialityhospital
AT udayvenkatmateti assessmentofdrugdruginteractionsinhypertensivepatientsatasuperspecialityhospital
AT venumadhavneerati assessmentofdrugdruginteractionsinhypertensivepatientsatasuperspecialityhospital
AT nimbagiriswamythiruthopu assessmentofdrugdruginteractionsinhypertensivepatientsatasuperspecialityhospital
AT srinivasmartha assessmentofdrugdruginteractionsinhypertensivepatientsatasuperspecialityhospital
_version_ 1718378980540678144